FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912774557> ?p ?o ?g. }

• W2912774557 abstract "Patients with oncohematological diseases, both children and adults, face high risks of thrombotic and hemorrhagic complications. About 40 % of pediatric patients with acute lymphoblastic leukemia develop bleedings, and the incidence of thrombosis in this disease ranges from 1 to 36 %. Most thromboses are associated with the use of central venous catheters and the use of L-asparaginase, which leads to a significant reduction in the synthesis of coagulation proteins. Massive hemorrhages account for two-thirds of all causes of early death in pediatric patients with acute myelogenous leukemia (AML). Absolute risks of death due to bleeding and leukostasis range from 1.8 % in the total population of children with AML to 14.3 % in a population with hyperleukocytosis more than 200 × 109 /l. The risk of thrombotic complications in children with AML varies between 3.4–11 %. In patients with AML, complex systemic coagulopathies may occur, such as disseminated intravascular coagulation (DIC), excessive fibrinolysis, or nonspecific proteolysis. This scale is not yet applicable due to the lack of research on its effectiveness in the pediatric population. The laboratory diagnostics of hemostasis is difficult due to the combined nature of thrombotic and hemorrhagic complications: bleeding, thrombosis and even DIC syndrome (combining both hyper- and hypocoagulation phases) can be expected in each specific patient with hemoblastosis. Because of the long-term nature of the treatment and the varying intensity of the various treatment units, the patient’s hemostasis during disease manifestation does not allow one to predict with any certainty the complications on induction or consolidation therapy. Involving all the components of the hemostasis system – vascular, platelet and plasma – into the pathological process makes prediction and diagnosis of thrombohemorrhagic complications impossible with the help of standard hemostatic tests and a general blood test, since these tests are designed to assess the concentrations of individual proteins and the functioning of individual components of the hemostatic system, and does not assess the balance between its procoagulant and anticoagulant components. Global hemostatic tests such as thromboelastography, thrombodynamics and thrombin generation test adequately reflect hypercoagulable conditions and can serve as a basis for the development of a new set of laboratory hemostasis tests. Conflict of interest. F.I. Ataullakhanov is co-founder of HemaCore LLC, which holds several patents and patent applications that are related to the diagnostic use of Thrombodynamics® (Ataullakhanov F.I., international patent applications: PCT/CH2007/000543 filing date 02.11.2007 and РСТ/RU2012/000570 filing date 16.07.2012). None of the other authors has any competing interests to declare." @default.
• W2912774557 created "2019-02-21" @default.
• W2912774557 creator A5026228594 @default.
• W2912774557 creator A5065753585 @default.
• W2912774557 creator A5077206646 @default.
• W2912774557 creator A5080077871 @default.
• W2912774557 creator A5083365365 @default.
• W2912774557 creator A5086377770 @default.
• W2912774557 creator A5087531377 @default.
• W2912774557 date "2019-01-22" @default.
• W2912774557 modified "2023-09-26" @default.
• W2912774557 title "Modern aspects of the pathogenesis, diagnosis and therapy of hemostasis disorders in children with acute leukemias" @default.
• W2912774557 cites W1659560878 @default.
• W2912774557 cites W1807362005 @default.
• W2912774557 cites W1968295431 @default.
• W2912774557 cites W1969149111 @default.
• W2912774557 cites W1969176274 @default.
• W2912774557 cites W1980267743 @default.
• W2912774557 cites W1983934932 @default.
• W2912774557 cites W1993989235 @default.
• W2912774557 cites W1997936886 @default.
• W2912774557 cites W1999933684 @default.
• W2912774557 cites W2009300493 @default.
• W2912774557 cites W2023858668 @default.
• W2912774557 cites W2037968757 @default.
• W2912774557 cites W2040037836 @default.
• W2912774557 cites W2045220907 @default.
• W2912774557 cites W2053611553 @default.
• W2912774557 cites W2055987519 @default.
• W2912774557 cites W2056370923 @default.
• W2912774557 cites W2057118034 @default.
• W2912774557 cites W2063830152 @default.
• W2912774557 cites W2068340285 @default.
• W2912774557 cites W2073193043 @default.
• W2912774557 cites W2090011336 @default.
• W2912774557 cites W2094330985 @default.
• W2912774557 cites W2097682287 @default.
• W2912774557 cites W2106459062 @default.
• W2912774557 cites W2110985695 @default.
• W2912774557 cites W2116288469 @default.
• W2912774557 cites W2116293480 @default.
• W2912774557 cites W2124034635 @default.
• W2912774557 cites W2132136287 @default.
• W2912774557 cites W2146263025 @default.
• W2912774557 cites W2166281502 @default.
• W2912774557 cites W2201493202 @default.
• W2912774557 cites W2211581164 @default.
• W2912774557 cites W2322688915 @default.
• W2912774557 cites W2330225383 @default.
• W2912774557 cites W2397341093 @default.
• W2912774557 cites W2399680513 @default.
• W2912774557 cites W2410632968 @default.
• W2912774557 cites W2471172931 @default.
• W2912774557 cites W2488948813 @default.
• W2912774557 cites W2510579189 @default.
• W2912774557 cites W2569961315 @default.
• W2912774557 cites W2587626377 @default.
• W2912774557 cites W2606949762 @default.
• W2912774557 cites W2612045376 @default.
• W2912774557 cites W2751546960 @default.
• W2912774557 cites W2751656793 @default.
• W2912774557 cites W2767859581 @default.
• W2912774557 cites W4242105303 @default.
• W2912774557 cites W1995935980 @default.
• W2912774557 doi "https://doi.org/10.17650/2311-1267-2018-5-4-74-85" @default.
• W2912774557 hasPublicationYear "2019" @default.
• W2912774557 type Work @default.
• W2912774557 sameAs 2912774557 @default.
• W2912774557 citedByCount "1" @default.
• W2912774557 countsByYear W29127745572021 @default.
• W2912774557 crossrefType "journal-article" @default.
• W2912774557 hasAuthorship W2912774557A5026228594 @default.
• W2912774557 hasAuthorship W2912774557A5065753585 @default.
• W2912774557 hasAuthorship W2912774557A5077206646 @default.
• W2912774557 hasAuthorship W2912774557A5080077871 @default.
• W2912774557 hasAuthorship W2912774557A5083365365 @default.
• W2912774557 hasAuthorship W2912774557A5086377770 @default.
• W2912774557 hasAuthorship W2912774557A5087531377 @default.
• W2912774557 hasBestOaLocation W29127745571 @default.
• W2912774557 hasConcept C126322002 @default.
• W2912774557 hasConcept C141071460 @default.
• W2912774557 hasConcept C177713679 @default.
• W2912774557 hasConcept C187212893 @default.
• W2912774557 hasConcept C2777432695 @default.
• W2912774557 hasConcept C2778461978 @default.
• W2912774557 hasConcept C2778589496 @default.
• W2912774557 hasConcept C2778734968 @default.
• W2912774557 hasConcept C2779134260 @default.
• W2912774557 hasConcept C2779936836 @default.
• W2912774557 hasConcept C2780011451 @default.
• W2912774557 hasConcept C2780868729 @default.
• W2912774557 hasConcept C2908647359 @default.
• W2912774557 hasConcept C71924100 @default.
• W2912774557 hasConcept C99454951 @default.
• W2912774557 hasConceptScore W2912774557C126322002 @default.
• W2912774557 hasConceptScore W2912774557C141071460 @default.
• W2912774557 hasConceptScore W2912774557C177713679 @default.
• W2912774557 hasConceptScore W2912774557C187212893 @default.
• W2912774557 hasConceptScore W2912774557C2777432695 @default.
• W2912774557 hasConceptScore W2912774557C2778461978 @default.

• next